Immune System Diseases: Page 3

Hematology thrives with decentralized approaches

The basis of hematology testing is the complete blood count (CBC), which provides information on blood components: hemoglobin, hematocrit, red blood cells, white blood cells, reticulocytes, and platelets. The CBC is run as part of the normal workup in an annual health exam and for every inpatient. A drop of blood is placed on a microscope slide and stained. The slide is then examined under a microscope and the cells are analyzed.

November 20, 2019

Blood-based biomarkers home in on PTSD in war zone veterans

For the study, the investigators examined war zone-exposed veterans of the Iraq and Afghanistan conflicts who had confirmed PTSD, as well as war zone-deployed veterans as healthy controls. The subjects were recruited from New York City-based Veterans Affairs (VA) medical centers and from other regional VA medical centers, veterans' service organizations, and the general community.

September 16, 2019

Babesiosis testing makes strides with FDA clearances

Ticks are arachnids: Small crawling bugs with eight legs that are related to spiders and mites. They are also parasites and feed on the blood of humans and animals. Ticks are vectors due to their disease transmission capability.

May 14, 2019

Microfluidic device could detect Ebola virus earlier

Developed by researcher Ke Du, PhD, at the Rochester Institute of Technology, the device uses clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing technology to monitor and detect RNA markers for Ebola, a highly contagious virus for which there are limited treatments. Individuals in areas where Ebola infections are common are often required to take a blood test before they can travel.

May 5, 2019

Kalorama's notable product launches for clinical labs in Q1 2019

In the POC segment, one of the breakthrough approvals from the U.S. Food and Drug Administration (FDA) was for the Sangia total prostate-specific antigen (PSA) test by Opko Health (Woburn, MA) in January. The Sangia test is the first POC test that quantitatively measures total PSA in capillary whole blood, and it is approved for use with the digital rectal exam (DRE) to screen for prostate cancer in men 50 years and older. The test can be administered with a finger prick and results are generated in 12 minutes.

April 24, 2019

Labs gear up to diagnose novel fungal infection

In the past few years, more than 600 cases of an emerging fungal infection called Candida auris have been identified in 12 U.S. states, according to the CDC.

April 14, 2019

Most Popular

Genetic causes identified for three rare diseases

Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease

SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests

Duke University researchers discover biomarkers may identify early pancreatic cancer risk

Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics

Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition